NO174630C - Fremgangsmåte ved fremstilling av en vaksine mot streptokokkinfeksjoner - Google Patents
Fremgangsmåte ved fremstilling av en vaksine mot streptokokkinfeksjonerInfo
- Publication number
- NO174630C NO174630C NO883763A NO883763A NO174630C NO 174630 C NO174630 C NO 174630C NO 883763 A NO883763 A NO 883763A NO 883763 A NO883763 A NO 883763A NO 174630 C NO174630 C NO 174630C
- Authority
- NO
- Norway
- Prior art keywords
- preparing
- streptococcal infections
- bacteria
- vaccine against
- against streptococcal
- Prior art date
Links
- 206010061372 Streptococcal infection Diseases 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 241000193996 Streptococcus pyogenes Species 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001662 opsonic effect Effects 0.000 abstract 1
- 108010010318 streptococcal M protein Proteins 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/879—Salmonella
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/885—Streptococcus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/088,626 US5162226A (en) | 1987-08-24 | 1987-08-24 | Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
Publications (4)
Publication Number | Publication Date |
---|---|
NO883763D0 NO883763D0 (no) | 1988-08-23 |
NO883763L NO883763L (no) | 1989-02-27 |
NO174630B NO174630B (no) | 1994-02-28 |
NO174630C true NO174630C (no) | 1994-06-08 |
Family
ID=22212456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO883763A NO174630C (no) | 1987-08-24 | 1988-08-23 | Fremgangsmåte ved fremstilling av en vaksine mot streptokokkinfeksjoner |
Country Status (12)
Country | Link |
---|---|
US (1) | US5162226A (no) |
EP (1) | EP0305279B1 (no) |
JP (1) | JPH02420A (no) |
AT (1) | ATE120487T1 (no) |
AU (1) | AU631524B2 (no) |
CA (1) | CA1341255C (no) |
DE (1) | DE3853454T2 (no) |
DK (1) | DK472988A (no) |
FI (1) | FI97603C (no) |
HU (1) | HU205263B (no) |
NO (1) | NO174630C (no) |
PT (1) | PT88329B (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6254874B1 (en) | 1995-04-13 | 2001-07-03 | President And Fellows Of Harvard College | Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same |
US6355255B1 (en) * | 1998-12-07 | 2002-03-12 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US5846547A (en) * | 1996-01-22 | 1998-12-08 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US6406692B1 (en) * | 1997-10-31 | 2002-06-18 | New Horizons Diagnostics Corp | Composition for treatment of an ocular bacterial infection |
US6399098B1 (en) | 1997-10-31 | 2002-06-04 | New Horizons Diagnostics Corp | Composition for treating dental caries caused by streptococcus mutans |
US7232576B2 (en) | 1997-10-31 | 2007-06-19 | New Horizons Diagnostics Corp | Throat lozenge for the treatment of Streptococcus Group A |
US20020136712A1 (en) * | 1997-10-31 | 2002-09-26 | Fischetti Vincent | Bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of colonization and infections caused by streptococcus pneumoniae |
US6752988B1 (en) * | 2000-04-28 | 2004-06-22 | New Horizons Diagnostic Corp | Method of treating upper resiratory illnesses |
US20030129146A1 (en) * | 1997-10-31 | 2003-07-10 | Vincent Fischetti | The use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US6399097B1 (en) | 1997-10-31 | 2002-06-04 | New Horizons Diagnostics Corporation | Composition for treatment of a bacterial infection of the digestive tract |
US6428784B1 (en) * | 1997-10-31 | 2002-08-06 | New Horizons Diagnostics Corp | Vaginal suppository for treating group B Streptococcus infection |
US20030129147A1 (en) * | 1997-10-31 | 2003-07-10 | Vincent Fischetti | Use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US6277399B1 (en) | 1997-10-31 | 2001-08-21 | New Horizon Diagnostics Corporation | Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
US6432444B1 (en) | 1997-10-31 | 2002-08-13 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymes for treating dermatological infections |
US6423299B1 (en) | 1997-10-31 | 2002-07-23 | Vincent Fischetti | Composition for treatment of a bacterial infection of an upper respiratory tract |
US6056954A (en) | 1997-10-31 | 2000-05-02 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses |
US20030082110A1 (en) * | 1997-10-31 | 2003-05-01 | Vincent Fischetti | Use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US20020127215A1 (en) * | 1999-09-14 | 2002-09-12 | Lawrence Loomis | Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections |
US7063837B2 (en) * | 1999-09-14 | 2006-06-20 | New Horizons Diagnostics Corp | Syrup composition containing phage associated lytic enzymes |
US7256265B2 (en) * | 1999-12-03 | 2007-08-14 | Regents Of The University Of Minnesota | Streptococcal C5a peptidase vaccine |
US20020187136A1 (en) * | 2000-04-28 | 2002-12-12 | Lawrence Loomis | Use of bacterial phage associated lysing enzymes for treating various illnesses |
US6395504B1 (en) | 2000-09-01 | 2002-05-28 | New Horizons Diagnostics Corp. | Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants |
EP1333854A4 (en) * | 2000-11-02 | 2005-10-05 | New Horizons Diagnostics Corp | USE OF BACTERIAL PHAGS IN CONNECTION WITH LYSEENZYMS FOR PREVENTING FOOD DRUGS |
US20040213765A1 (en) * | 2001-07-13 | 2004-10-28 | Vincent Fischetti | Use of bacterial phage associated lytic enzymes to prevent food poisoning |
MXPA04003852A (es) * | 2001-10-26 | 2005-02-17 | Univ Tennessee Res Foundation | Composiciones de vacuna estreptococica multivalente, y metodos para sus uso. |
US7255867B2 (en) * | 2002-11-15 | 2007-08-14 | Id Biomedical Corporation Of Quebec | Vaccine |
DK2356135T3 (en) | 2008-11-05 | 2017-12-04 | Wyeth Llc | IMMUNOGEN MULTICOMPONENT COMPOSITION FOR THE PREVENTION OF BETA-HAEMOLYTIC STRUCTURAL TOC (BHS) DISEASE |
WO2014013375A1 (en) | 2012-07-16 | 2014-01-23 | Pfizer Inc. | Saccharides and uses thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2480779B2 (fr) | 1979-08-30 | 1986-07-18 | Anvar | Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur |
US4735801A (en) * | 1982-09-07 | 1988-04-05 | Board Of Trustees Of Leland Stanford Jr. University | Novel non-reverting salmonella live vaccines |
US4550081A (en) * | 1980-05-19 | 1985-10-29 | The Board Of Trustees Of The Leland Stanford Jr. University | Non-reverting salmonella |
US4284537A (en) | 1980-07-03 | 1981-08-18 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate of streptococcal M protein peptide vaccine |
US4666847A (en) | 1981-01-16 | 1987-05-19 | Collaborative Research, Inc. | Recombinant DNA means and method |
WO1982003088A1 (en) * | 1981-03-09 | 1982-09-16 | Corp Cetus | Vaccines |
US4625252A (en) | 1981-09-03 | 1986-11-25 | Basf Aktiengesellschaft | Guide system and magnetic tape cassette comprising such a system |
US4454121A (en) * | 1982-07-27 | 1984-06-12 | The University Of Tennessee Research Corporation | Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes |
US4521334A (en) | 1982-07-27 | 1985-06-04 | The University Of Tennesse Research Corporation | Synthetic polypeptide fragments |
US4597967A (en) * | 1982-07-27 | 1986-07-01 | The University Of Tennessee Research Corp. | Synthetic polypeptide fragments |
US4588585A (en) | 1982-10-19 | 1986-05-13 | Cetus Corporation | Human recombinant cysteine depleted interferon-β muteins |
US4518584A (en) | 1983-04-15 | 1985-05-21 | Cetus Corporation | Human recombinant interleukin-2 muteins |
US4919930A (en) * | 1983-06-10 | 1990-04-24 | University Of Tennessee Research Corporation | Synthetic M proteins-streptococci type 5 |
US4784948A (en) * | 1983-08-10 | 1988-11-15 | The Rockefeller University | Production of streptococcal m protein immunogens and molecular probes |
AU589114B2 (en) * | 1984-02-01 | 1989-10-05 | Enterovax Limited | Genetically engineered bacteria useful as a vaccine |
US4666846A (en) | 1984-02-17 | 1987-05-19 | Eli Lilly And Company | Novel cloning vectors containing selectable genetic markers for use in streptomyces and related organisms |
-
1987
- 1987-08-24 US US07/088,626 patent/US5162226A/en not_active Expired - Lifetime
-
1988
- 1988-08-22 AT AT88402132T patent/ATE120487T1/de active
- 1988-08-22 DE DE3853454T patent/DE3853454T2/de not_active Expired - Lifetime
- 1988-08-22 CA CA000575374A patent/CA1341255C/en not_active Expired - Fee Related
- 1988-08-22 EP EP88402132A patent/EP0305279B1/en not_active Expired - Lifetime
- 1988-08-22 FI FI883876A patent/FI97603C/fi not_active IP Right Cessation
- 1988-08-23 HU HU884433A patent/HU205263B/hu not_active IP Right Cessation
- 1988-08-23 JP JP63209327A patent/JPH02420A/ja active Pending
- 1988-08-23 NO NO883763A patent/NO174630C/no unknown
- 1988-08-23 AU AU21451/88A patent/AU631524B2/en not_active Expired
- 1988-08-24 DK DK472988A patent/DK472988A/da not_active Application Discontinuation
- 1988-08-24 PT PT88329A patent/PT88329B/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5162226A (en) | 1992-11-10 |
EP0305279B1 (en) | 1995-03-29 |
NO883763L (no) | 1989-02-27 |
CA1341255C (en) | 2001-06-19 |
ATE120487T1 (de) | 1995-04-15 |
FI97603B (fi) | 1996-10-15 |
HU205263B (en) | 1992-04-28 |
DK472988D0 (da) | 1988-08-24 |
PT88329A (pt) | 1989-06-30 |
NO174630B (no) | 1994-02-28 |
FI883876A (fi) | 1989-02-25 |
AU631524B2 (en) | 1992-12-03 |
DK472988A (da) | 1989-02-25 |
JPH02420A (ja) | 1990-01-05 |
NO883763D0 (no) | 1988-08-23 |
EP0305279A1 (en) | 1989-03-01 |
FI883876A0 (fi) | 1988-08-22 |
AU2145188A (en) | 1989-03-09 |
PT88329B (pt) | 1995-07-03 |
DE3853454T2 (de) | 1995-11-09 |
HUT50048A (en) | 1989-12-28 |
FI97603C (fi) | 1997-01-27 |
DE3853454D1 (de) | 1995-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO174630C (no) | Fremgangsmåte ved fremstilling av en vaksine mot streptokokkinfeksjoner | |
EP0692031A4 (en) | HETEROLOGOUS ANTIGENS PRESENT IN VACCINE STRAINS WITH LIVING CELLS | |
FI93310B (fi) | Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan | |
AU2001276619A1 (en) | Immunisation against chlamydia pneumoniae | |
ES531986A0 (es) | Un metodo de producir una forma geneticamente estable de vidrio cholerae | |
AU8314587A (en) | New oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines | |
EP0325191A3 (en) | Composition and method for protecting against diseases caused by microorganisms | |
SE8502162L (sv) | Framstellning av protein g och/eller fragment derav | |
EP0302887A4 (en) | ANTIGENS, ANTIBODIES, BACTERIAL VACCINES AND THEIR PRODUCTION METHOD. | |
PL303482A1 (en) | Vaccine against infection with streptococcus suis, streptococcus suis polypeptide and method of preparing such vaccine | |
ATE73349T1 (de) | Hepatitisoberflaechenantigenpartikelvakzin. | |
FI952144A0 (fi) | Ei tyypittävissä olevan Haemphilus influenzaen puhdistettu P5 proteiini rokotteena ei tyypittävissä olevalle Haemophilus influenzae -kannalle | |
ATE107516T1 (de) | Pasteurella-impfstoff. | |
DK125887A (da) | Beskyttelse af heste mod streptococcus equi | |
IE810618L (en) | Pasteurella vaccines | |
ES8401722A1 (es) | Procedimiento de obtencion de vacunas contra el patogeno h influenzae tipo b. | |
PT1161562E (pt) | Sequências deletadas em m. bovis bcg/m. bovis ou m. tuberculosis, processo de detecção das micobactérias utilizando as referidas sequências e vacinas | |
AU7547987A (en) | Method of preparation and use for feline leukemia virus antigens | |
FI971402A (fi) | Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi | |
SE8403929L (sv) | Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas | |
AU2713488A (en) | Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process |